The Canadian Hypertension Education Program (CHEP) 2011 Guidelines for Pharmacists

Wilkins K Campbell N Joffres M . Blood pressure in Canadian adults. Health Reports 2010;21:1–10.

Kearney PM Whelton M Reynolds K . Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22:11–19.

Egan BM Zhao Y Axon RN . US trends in prevalence, awareness, treatment and control of hypertension, 1988–2008. JAMA 2010;303:2043–50.

McLean DL McAlister FA Johnson J . A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists—Hypertension (SCRIP-HTN). Arch Intern Med 2008;168(21):2355–61.

Tobari H Arimoto T Shimojo N . Physician-pharmacist cooperation program for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens 2010;23(10):1144–52.

Weber CA Ernst ME Sezate GS . Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010;170(18):1634–9.

Carter BL Ardery G Dawson JD . Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009;169(21):1996–2002.

Hunt JS Siemienczuk J Pape G . A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008;23(12):1966–72.

Machado M Bajcar J Guzzo GC Einarson TR . Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007;41(11):1770–81.

Rabi DM Daskalopoulou SS Padwal RS . On behalf of the Canadian Hypertension Education Program. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011;27(4):415–33.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(suppl 1):S1–S201.

Genest J McPherson R Frolich J . 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult — 2009 recommendations. Can J Cardiol 2009;25(10):567–79.

National Institutes of Health. DASH eating plan — your guide to lowering your blood pressure with DASH. Available: www.nhlbi.nih.gov/health/public/heart/hbp/dash/newdash.pdf (accessed Oct. 6, 2011).

Leonardi-Bee J Bath PMW Phillips SJ Sandercock PAG . Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315–20.

Lindsay MP Gubitz G Bayley M Hill MD Davies-Schinkel C Singh S . Canadian Best Practice Recommendations for Stroke Care (Update 2010). Canadian Stroke Network, 2010.

Sipahi I Debanne S Rowland D Simon D Fang J . Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomized controlled trials. Lancet Oncology 2010;11(7):627–36.

Cushman W Evans G Byington R Goff D Grimm R Cutler J . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;10:1286–97.